Tennessee's Senate Bill 489, introduced on January 29, 2025, aims to regulate the medical cannabis market while enhancing consumer protection and safety. The bill outlines several key provisions that address the packaging, labeling, and marketing of medical cannabis and cannabis-infused products.
One of the primary focuses of Senate Bill 489 is the establishment of strict packaging requirements. It mandates that medical cannabis products must be packaged in resealable containers by dispensaries or manufacturers, ensuring that consumers can safely store their products. Additionally, the bill requires that products be placed in exit packages that meet specific standards before leaving the dispensary, further safeguarding against misuse.
Labeling is another critical aspect of the bill. It introduces standardized serving sizes for edible cannabis products, capping active THC content at ten milligrams per serving. This measure aims to provide consumers with clear information about their intake, promoting responsible use. Furthermore, the bill stipulates that the total active THC in a sealed internal package cannot exceed one hundred milligrams, which is designed to prevent overconsumption.
The bill also addresses marketing practices, particularly concerning location-based advertising. It prohibits marketing directed at mobile devices unless the application is installed by the device owner, who must be at least eighteen years old, and includes an easy opt-out feature. This provision seeks to protect consumers from unsolicited advertisements and ensure that marketing practices are ethical.
While the bill has garnered support for its consumer protection measures, it has also sparked debates regarding the implications for the medical cannabis industry. Critics argue that stringent regulations could hinder access for patients who rely on these products for treatment. Proponents, however, emphasize the importance of safety and informed consumption.
As Tennessee continues to navigate the complexities of medical cannabis legislation, Senate Bill 489 represents a significant step toward establishing a regulated framework that prioritizes consumer safety while addressing the needs of the medical community. The bill's future will depend on ongoing discussions and potential amendments as it moves through the legislative process.